Citations (190)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (30)
David J Kopsky, Karolina M Szadek, Patrick Schober, Alexander F J E Vrancken & Monique A H Steegers. (2022) Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review. Journal of Pain Research 15, pages 479-496.
Read now
Read now
Kalliopi Pafili & Nikolaos Papanas. (2021) Considerations for single- versus multiple-drug pharmacotherapy in the management of painful diabetic neuropathy. Expert Opinion on Pharmacotherapy 22:16, pages 2267-2280.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Alice Baroncini, Jörg Eschweiler, Markus Tingart & Valentin Quack. (2021) Opioids for chronic low back pain management: a Bayesian network meta-analysis. Expert Review of Clinical Pharmacology 14:5, pages 635-641.
Read now
Read now
Mélissa Cuménal, Marie Selvy, Nicolas Kerckhove, Célian Bertin, Margaux Morez, Christine Courteix, Jérôme Busserolles & David Balayssac. (2021) The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials. Expert Opinion on Drug Safety 20:1, pages 51-68.
Read now
Read now
Shazli Azmi, Uazman Alam, Jamie Burgess & Rayaz A. Malik. (2021) State-of-the-art pharmacotherapy for diabetic neuropathy. Expert Opinion on Pharmacotherapy 22:1, pages 55-68.
Read now
Read now
R. Freynhagen, C. Elling, T. Radic, M. Sohns, H. Liedgens, D. James, R. McCool & M. Edwards. (2021) Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials. Current Medical Research and Opinion 37:1, pages 89-100.
Read now
Read now
Nebojsa Nick Knezevic, Filip Jovanovic, Kenneth D. Candido & Ivana Knezevic. (2020) Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions – a review of clinical trials. Expert Opinion on Pharmacotherapy 21:18, pages 2231-2248.
Read now
Read now
Ulderico Freo, Patrizia Romualdi & Hans G Kress. (2019) Tapentadol for neuropathic pain: a review of clinical studies. Journal of Pain Research 12, pages 1537-1551.
Read now
Read now
R. Ffrench-O’Carroll, H. Steinhaeuser, S. Duff, J. Close, J. McNamara, N. Ahmed, M. Murray, T. Rice & S. Immanni. (2019) A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section. Current Medical Research and Opinion 35:6, pages 975-981.
Read now
Read now
Diana S Meske, Oluwadolapo D Lawal, Harrison Elder, Valerie Langberg, Florence Paillard & Nathaniel Katz. (2018) Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials. Journal of Pain Research 11, pages 923-934.
Read now
Read now
Nikolaos Papanas & Dan Ziegler. (2016) Emerging drugs for diabetic peripheral neuropathy and neuropathic pain. Expert Opinion on Emerging Drugs 21:4, pages 393-407.
Read now
Read now
M. Förster, S. Helfert, R. Dierschke, M. Großkopf, P. Hüllemann, T. Keller, R. Baron & A. Binder. (2016) Evaluation of the antihyperalgesic effect of tapentadol in two human evoked pain models – the TapCapMentho pilot trial. Expert Opinion on Pharmacotherapy 17:13, pages 1717-1725.
Read now
Read now
Nalini Vadivelu, Alice Kai, Benjamin Maslin, Gopal Kodumudi, Aron Legler & Jack M Berger. (2015) Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 95-105.
Read now
Read now
Flaminia Coluzzi, Robert B Raffa, Joseph Pergolizzi, Alessandra Rocco, Pamela Locarini, Natalia Cenfra, Giuseppe Cimino & Consalvo Mattia. (2015) Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease. Journal of Pain Research 8, pages 229-238.
Read now
Read now
Nebojsa Nick Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth D Candido. (2015) Unique pharmacology of tapentadol for treating acute and chronic pain. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1475-1492.
Read now
Read now
Charles V. Pollack$suffix/text()$suffix/text() & Eugene R. Viscusi. (2015) Improving acute pain management in emergency medicine. Hospital Practice 43:1, pages 36-45.
Read now
Read now
Howard S. Smith, Robert B. Raffa, Joseph V. Pergolizzi, Robert Taylor & Ronald J. Tallarida. (2014) Combining Opioid and Adrenergic Mechanisms for Chronic Pain. Postgraduate Medicine 126:4, pages 98-114.
Read now
Read now
Barbara Gardella, Daniele Porru, Massimo Allegri, Stefano Bogliolo, Anna Daniela Iacobone, Cristina Minella, Rossella Elena Nappi, Simone Ferrero & Arsenio Spinillo. (2014) Pharmacokinetic considerations for therapies used to treat interstitial cystitis. Expert Opinion on Drug Metabolism & Toxicology 10:5, pages 673-684.
Read now
Read now
Bansri Desai, Erin Freeman, Ellen Huang, Anna Hung, Edward Knapp, Ian M Breunig, Mary L McPherson & Fadia T Shaya. (2014) Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy. Expert Review of Clinical Pharmacology 7:2, pages 203-209.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Aaron I Vinik & Carolina M Casellini. (2013) Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin. Diabetes, Metabolic Syndrome and Obesity 6, pages 57-78.
Read now
Read now
Nalini Sehgal, James Colson & Howard S Smith. (2013) Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Review of Neurotherapeutics 13:11, pages 1201-1220.
Read now
Read now
A. Schwittay, C. Schumann, B. C. Litzenburger & K. Schwenke. (2013) Tapentadol Prolonged Release for Severe Chronic Pain: Results of a Noninterventional Study Involving General Practitioners and Internists. Journal of Pain & Palliative Care Pharmacotherapy 27:3, pages 225-234.
Read now
Read now
Sebastiano Mercadante, Giampiero Porzio, Federica Aielli, Claudio Adile, Lucilla Verna, Corrado Ficorella, Antonello Giarratano & Alessandra Casuccio. (2013) Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Current Medical Research and Opinion 29:6, pages 661-666.
Read now
Read now
Sebastiano Mercadante, Giampiero Porzio, Patrizia Ferrera, Federica Aielli, Claudio Adile, Corrado Ficorella, Antonello Giarratano & Alessandra Casuccio. (2012) Tapentadol in cancer pain management: a prospective open-label study. Current Medical Research and Opinion 28:11, pages 1775-1779.
Read now
Read now
Ilona Steigerwald, Matthias Müller, Anthony Davies, Daniel Samper, Rainer Sabatowski, Ralf Baron, Sylvie Rozenberg, Anna Szczepanska-Szerej, Antonio Gatti & Hans G. Kress. (2012) Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. Current Medical Research and Opinion 28:6, pages 911-936.
Read now
Read now
John H. Peniston, Xiaojun Hu, Susan L. Potts, Matthew S. Wieman & Dennis C. Turk. (2012) Tolerability of Concomitant Use of Selective Serotonin Reuptake Inhibitors or Serotonin-Norepinephrine Reuptake Inhibitors and Oxymorphone Extended Release. Postgraduate Medicine 124:2, pages 114-122.
Read now
Read now
Sheila M. Seed, Kaelen C. Dunican, Ann M. Lynch & Alicia R. Desilets. (2012) An Update in Options for the Treatment of Pain: A Review of New Opioid Formulations. Hospital Practice 40:1, pages 166-175.
Read now
Read now
Craig T Hartrick & Jose Rafael Rodríguez Hernandez. (2012) Tapentadol for pain: a treatment evaluation. Expert Opinion on Pharmacotherapy 13:2, pages 283-286.
Read now
Read now
Nalini Vadivelu, Alexander Timchenko, Yili Huang & Raymond Sinatra. (2011) Tapentadol extended-release for treatment of chronic pain: a review. Journal of Pain Research 4, pages 211-218.
Read now
Read now
Articles from other publishers (160)
Karl V. L. Kraft, Teresa Backmund, Leopold Eberhart, Ann-Kristin Schubert, Hanns-Christian Dinges, Maria K. Hagen & Markus Gehling. (2023) Does opioid therapy enhance quality of life in patients suffering from chronic non-malignant pain? A systematic review and meta-analysis. British Journal of Pain.
Crossref
Crossref
Jade I. Basem, Fatoumata N. Bah & Neel D. Mehta. (2023) A Brief Review on the Novel Therapies for Painful Diabetic Neuropathy. Current Pain and Headache Reports 27:9, pages 299-305.
Crossref
Crossref
Alessandra Oliveira Silva, Danielle Aparecida de Oliveira Marrafon, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres & Marília Gabriella Alves Goulart Pereira. (2023) Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. Journal of Pharmaceutical and Biological Sciences 11:1, pages 18-25.
Crossref
Crossref
Boris Hait. 2023. Pain Management - From Acute to Chronic and Beyond [Working Title]. Pain Management - From Acute to Chronic and Beyond [Working Title].
MP Priyanka, KhajaJaved Khan & MN Satish Kumar. (2023) Dry beriberi at the pain clinic – B1 deficiency neuropathic pain post gastric bypass. Indian Journal of Pain 37:1, pages 56.
Crossref
Crossref
Zahra Nochi, Hossein Pia, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Francesca Fardo, Bernd Genser, Marcus Goetz, Anna V. Kostenko, Caterina Leone, Thomas Li, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Alexandre Stouffs, Irene Tracey, Iñaki F. Troconiz, Andrea Truini, Johannes Van Niel, Jose Miguel Vela, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Hatice Tankisi, Nanna B. Finnerup, Keith G. Phillips & Rolf-Detlef Treede. (2022) IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET). Trials 23:1.
Crossref
Crossref
Lawrence Blonde, Guillermo E. Umpierrez, S. Sethu Reddy, Janet B. McGill, Sarah L. Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A. DeFronzo, Daniel Einhorn, Rodolfo J. Galindo, Thomas W. Gardner, Rajesh Garg, W. Timothy Garvey, Irl B. Hirsch, Daniel L. Hurley, Kenneth Izuora, Mikhail Kosiborod, Darin Olson, Shailendra B. Patel, Rodica Pop-Busui, Archana R. Sadhu, Susan L. Samson, Carla Stec, William V. TamborlaneJr.Jr., Katherine R. Tuttle, Christine Twining, Adrian Vella, Priyathama Vellanki & Sandra L. Weber. (2022) American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice 28:10, pages 923-1049.
Crossref
Crossref
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini & Rolf-Detlef Treede. (2022) IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity. Trials 23:1.
Crossref
Crossref
Jennifer Mirabella, Deepa Ravi, Angela L. Chiew, Nicholas A. Buckley & Betty S. Chan. (2022) Prescribing trend of tapentadol in a Sydney local health district. British Journal of Clinical Pharmacology 88:9, pages 3929-3935.
Crossref
Crossref
Atefeh Noori, Behnam Sadeghirad, Li Wang, Reed A.C. Siemieniuk, Mostafa Shokoohi, Elena Kum, Mark Jeddi, Luis Montoya, Patrick J. Hong, Edward Zhou, Rachel J. Couban, David N. Juurlink, Lehana Thabane, Mohit Bhandari, Gordon H. Guyatt & Jason W. Busse. (2022) Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. British Journal of Anaesthesia 129:3, pages 394-406.
Crossref
Crossref
Gordon Sloan, Uazman Alam, Dinesh Selvarajah & Solomon Tesfaye. (2022) The Treatment of Painful Diabetic Neuropathy. Current Diabetes Reviews 18:5.
Crossref
Crossref
Jonathan M. Hagedorn, Alyson M. Engle, Tony K. George, Jay Karri, Newaj Abdullah, Erik Ovrom, Jhon E. Bocanegra-Becerra & Ryan S. D'Souza. (2022) An overview of painful diabetic peripheral neuropathy: Diagnosis and treatment advancements. Diabetes Research and Clinical Practice 188, pages 109928.
Crossref
Crossref
Shu-Hao Du, Yi-Li Zheng, Yong-Hui Zhang, Ming-Wen Wang & Xue-Qiang Wang. (2022) The Last Decade Publications on Diabetic Peripheral Neuropathic Pain: A Bibliometric Analysis. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Martina Vincenzi, Michele Stanislaw Milella, Ginevra D’Ottavio, Daniele Caprioli, Ingrid Reverte & Daniela Maftei. (2022) Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain. Life 12:3, pages 398.
Crossref
Crossref
Michael D. Staudt, Tarun Prabhala, Breanna L. Sheldon, Nicholas Quaranta, Michael Zakher, Ravneet Bhullar, Julie G. Pilitsis & Charles E. Argoff. (2020) Current Strategies for the Management of Painful Diabetic Neuropathy. Journal of Diabetes Science and Technology 16:2, pages 341-352.
Crossref
Crossref
Raymond Price, Don Smith, Gary Franklin, Gary Gronseth, Michael Pignone, William S. David, Carmel Armon, Bruce A. Perkins, Vera Bril, Alexander Rae-Grant, John Halperin, Nicole Licking, Mary Dolan O'Brien, Scott R. Wessels, Leslie C. MacGregor, Kenneth Fink, Lawrence B. Harkless, Lindsay Colbert & Brian C. Callaghan. (2021) Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary. Neurology 98:1, pages 31-43.
Crossref
Crossref
. (2022)
12. Retinopathy, Neuropathy, and Foot Care:
Standards of Medical Care in Diabetes—2022
. Diabetes Care 45:Supplement_1, pages S185-S194.
Crossref
Crossref
Johan Røikjer & Niels Ejskjaer. 2022. From Obesity to Diabetes. From Obesity to Diabetes
309
328
.
Vladimir A. Parfenov & Mariya V. Konyashova. (2021) Treatment of painful diabetic neuropathy. Consilium Medicum 23:11, pages 841-846.
Crossref
Crossref
Lian Jingxuan, Ma Litian & Fu Jianfang. (2021) Different Drugs for the Treatment of Painful Diabetic Peripheral Neuropathy: A Meta-Analysis. Frontiers in Neurology 12.
Crossref
Crossref
Simona Cernea & Itamar Raz. (2021) Management of diabetic neuropathy. Metabolism 123, pages 154867.
Crossref
Crossref
G. Tosti & N. Attal. (2021) Trattamento farmacologico dei dolori neuropatici. EMC - Neurologia 21:3, pages 1-9.
Crossref
Crossref
Mayank Gupta, Nebojsa Nick Knezevic, Alaa Abd-Elsayed, Mahoua Ray, Kiran Patel & Bhavika Chowdhury. (2021) Treatment of Painful Diabetic Neuropathy—A Narrative Review of Pharmacological and Interventional Approaches. Biomedicines 9:5, pages 573.
Crossref
Crossref
Jasaswi Ray, Chinmaya Keshari Sahoo, Rajashree Mohanty, Rakesh Sahoo & Rajashree Dalai. (2021) A Review on Diabetic Peripheral Neuropathy. Journal of Drug Delivery and Therapeutics 11:2-S, pages 121-125.
Crossref
Crossref
Johan Røikjer, Carsten Dahl Mørch & Niels Ejskjaer. (2021) Diabetic Peripheral Neuropathy: Diagnosis and Treatment. Current Drug Safety 16:1, pages 2-16.
Crossref
Crossref
Cesar Margarit Ferri, Silvia Natoli, Paz Sanz-Ayan, Alberto Magni, Carlos Guerrero, Argelia Lara-Solares, Hiltrud Liedgens, Guido Thömmes & Ravi Karra. (2021)
Quality of life and functional outcomes with tapentadol prolonged release in chronic musculoskeletal pain:
post hoc
analysis
. Pain Management 11:2, pages 173-187.
Crossref
Crossref
Samantha C. Erosa, Paul R. Haffey, Neel Mehta & Amitabh Gulati. (2021) Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: a Systematic Review. Current Pain and Headache Reports 25:3.
Crossref
Crossref
. (2021)
11. Microvascular Complications and Foot Care:
Standards of Medical Care in Diabetes—2021
. Diabetes Care 44:Supplement_1, pages S151-S167.
Crossref
Crossref
Bart J Morlion, César Margarit, Imane Wild, Ravi Karra, Hiltrud Liedgens, Melanie Sohns & Gabriele Finco. (2021) Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study. Pain Management 11:1, pages 39-47.
Crossref
Crossref
V.N. Khramilin & O.S. Davydov. (2021) Painful diabetic polyneuropathy: evidence-based diagnosis and treatment. Russian Journal of Pain 19:4, pages 44.
Crossref
Crossref
Atsushi Sawada & Michiaki Yamakage. 2021. Chronic Pain Management in General and Hospital Practice. Chronic Pain Management in General and Hospital Practice
249
260
.
Nagy A. Mekhail, Charles E. Argoff, Rod S. Taylor, Christian Nasr, David L. Caraway, Bradford E. Gliner, Jeyakumar Subbaroyan & Elizabeth S. Brooks. (2020) High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials 21:1.
Crossref
Crossref
Amanda C. Peltier & Derek Wood. (2020) Management of Neuropathic Pain in Polyneuropathy. CONTINUUM: Lifelong Learning in Neurology 26:5, pages 1299-1322.
Crossref
Crossref
Ivan I. Dedov, Marina V. Shestakova, Alexander Y. Mayorov, Minara S. Shamkhalova, Olga Yu. Sukhareva, Gagik R. Galstyan, Alla Y. Tokmakova, Tatiana V. Nikonova, Elena V. Surkova, Irina V. Kononenko, Daria N. Egorova, Lyudmila I. Ibragimova, Ekaterina A. Shestakova, Inna I. Klefortova, Igor A. Sklyanik, Ivona Ya. Yarek-Martynova, Anastasia S. Severina, Sergey A. Martynov, Olga K. Vikulova, Viktor Y. Kalashnikov, Irina Z. Bondarenko, Irina S. Gomova, Elena G. Starostina, Alexander S. Ametov, Mikhail B. Antsiferov, Tatiana P. Bardymova, Irina A. Bondar, Farida V. Valeeva, Tatiana Y. Demidova, Ashot M. Mkrtumyan, Nina A. Petunina, Lyudmila A. Ruyatkina, Lyudmila A. Suplotova, Olga V. Ushakova & Yurii Sh. Khalimov. (2020) Diabetes mellitus type 2 in adults. Diabetes mellitus 23:2S, pages 4-102.
Crossref
Crossref
Ivan I. Dedov, Marina V. Shestakova, Alexander Y. Mayorov, Minara S. Shamkhalova, Tatiana V. Nikonova, Olga Y. Sukhareva, Elena V. Pekareva, Lyudmila I. Ibragimova, Margarita S. Mikhina, Gagik R. Galstyan, Alla Y. Tokmakova, Elena V. Surkova, Dmitry N. Laptev, Irina V. Kononenko, Daria N. Egorova, Inna I. Klefortova, Igor A. Sklyanik, Ivona Ya. Yarek-Martynova, Anastasia S. Severina, Sergey A. Martynov, Olga K. Vikulova, Viktor Y. Kalashnikov, Irina S. Gomova, Dmitry V. Lipatov, Elena G. Starostina, Alexander S. Ametov, Mikhail B. Antsiferov, Tatiana P. Bardymova, Irina A. Bondar, Farida V. Valeeva, Tatiana Y. Demidova, Vadim V. Klimontov, Ashot M. Mkrtumyan, Nina A. Petunina, Lyudmila A. Suplotova, Olga V. Ushakova, Yurii Sh. Khalimov & Lyudmila A. Ruyatkina. (2020) Diabetes mellitus type 1 in adults. Diabetes mellitus 23:1S, pages 42-114.
Crossref
Crossref
Uazman Alam, Gordon Sloan & Solomon Tesfaye. (2020) Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs. Drugs 80:4, pages 363-384.
Crossref
Crossref
Valeriu Ardeleanu, Alexandra Toma, Kalliopi Pafili, Nikolaos Papanas, Ion Motofei, Camelia Cristina Diaconu, Manfredi Rizzo & Anca Pantea Stoian. (2020) Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review. Medicina 56:1, pages 25.
Crossref
Crossref
Rajeev Chawla, SV Madhu, BM Makkar, Sujoy Ghosh, Banshi Saboo & Sanjay Kalra. (2020) RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian Journal of Endocrinology and Metabolism 24:1, pages 1.
Crossref
Crossref
. (2020)
11. Microvascular Complications and Foot Care:
Standards of Medical Care in Diabetes−2020
. Diabetes Care 43:Supplement_1, pages S135-S151.
Crossref
Crossref
Rajeev Chawla, S. V. Madhu, B. M. Makkar, Sujoy Ghosh, Banshi Saboo & Sanjay Kalra. (2020) RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. International Journal of Diabetes in Developing Countries 40:S1, pages 1-122.
Crossref
Crossref
Aaron I. Vinik, Carolina Casellini & Serina Neumann. 2020. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
275
353
.
Claudia Sommer, Petra Klose, Patrick Welsch, Frank Petzke & Winfried Häuser. (2019) Opioids for chronic non‐cancer neuropathic pain. An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks duration. European Journal of Pain 24:1, pages 3-18.
Crossref
Crossref
Robert A. SwarmJudith A. PaiceDoralina L. AnghelescuMadhuri AreJustine Yang BruceSorin BugaMarcin ChwistekCharles CleelandDavid CraigEllin GaffordHeather GreenleeEric HansenArif H. KamalMihir M. KamdarSusan LeGrandSean MackeyM. Rachel McDowellNatalie MorylLisle M. NabellSuzanne Nesbit, Nina O’ConnorMichael W. RabowElizabeth RickersonRebecca ShatskyJill SindtSusan G. UrbaJeanie M. Youngwerth, Lydia J. Hammond & Lisa A. Gurski. (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:8, pages 977-1007.
Crossref
Crossref
Tara SanftCrystal S. DenlingerSaro ArmenianK. Scott BakerGregory BroderickWendy Demark-WahnefriedDebra L. FriedmanMindy GoldmanMelissa HudsonNazanin KhakpourDivya KouraRobin M. LallyTerry S. LangbaumAllison L. McDonoughMichelle MeliskoKathi MooneyHalle C.F. MooreJavid J. MoslehiTracey O’ConnorLinda OverholserElectra D. PaskettLindsay PetersonWilliam PirlM. Alma RodriguezKathryn J. RuddySophia SmithKaren L. SyrjalaAmye TevaarwerkSusan G. UrbaPhyllis Zee, Nicole R. McMillianDeborah A. Freedman-Cass. (2019) NCCN Guidelines Insights: Survivorship, Version 2.2019. Journal of the National Comprehensive Cancer Network 17:7, pages 784-794.
Crossref
Crossref
Eva L. Feldman, Brian C. Callaghan, Rodica Pop-Busui, Douglas W. Zochodne, Douglas E. Wright, David L. Bennett, Vera Bril, James W. Russell & Vijay Viswanathan. (2019) Diabetic neuropathy. Nature Reviews Disease Primers 5:1.
Crossref
Crossref
Daniel Bates, B Carsten Schultheis, Michael C Hanes, Suneil M Jolly, Krishnan V Chakravarthy, Timothy R Deer, Robert M Levy & Corey W Hunter. (2019) A Comprehensive Algorithm for Management of Neuropathic Pain. Pain Medicine 20:Supplement_1, pages S2-S12.
Crossref
Crossref
. (2019)
11. Microvascular Complications and Foot Care:
Standards of Medical Care in Diabetes—2019
. Diabetes Care 42:Supplement_1, pages S124-S138.
Crossref
Crossref
Christopher M. Navas, Nihal K. Patel & Brian E. Lacy. (2019) Symptomatic Management of Gastroparesis. Gastrointestinal Endoscopy Clinics of North America 29:1, pages 55-70.
Crossref
Crossref
Alicia J. Jenkins, Emma Scott, Jordan Fulcher, Gary Kilov & Andrzej S. Januszewski. 2019. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting
113
177
.
Aaron I. Vinik, Carolina Casellini & Serina Neumann. 2019. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
1
79
.
Jason W. Busse, Li Wang, Mostafa Kamaleldin, Samantha Craigie, John J. Riva, Luis Montoya, Sohail M. Mulla, Luciane C. Lopes, Nicole Vogel, Eric Chen, Karin Kirmayr, Kyle De Oliveira, Lori Olivieri, Alka Kaushal, Luis E. Chaparro, Inna Oyberman, Arnav Agarwal, Rachel Couban, Ludwig Tsoi, Tommy Lam, Per Olav Vandvik, Sandy Hsu, Malgorzata M. Bala, Stefan SchandelmaierAnne Scheidecker, Shanil Ebrahim, Vahid Ashoorion, Yasir Rehman, Patrick J. Hong, Stephanie Ross, Bradley C. Johnston, Regina KunzXin Sun, Norman Buckley, Daniel I. Sessler & Gordon H. Guyatt. (2018) Opioids for Chronic Noncancer Pain. JAMA 320:23, pages 2448.
Crossref
Crossref
Linda Huang, Dilafruz Khakimova & Jennifer Pruskowski. (2018) Opioids for Neuropathic Pain #363. Journal of Palliative Medicine 21:12, pages 1806-1807.
Crossref
Crossref
Emma D. Deeks. (2018) Tapentadol Prolonged Release: A Review in Pain Management. Drugs 78:17, pages 1805-1816.
Crossref
Crossref
Jarosław Woroń. (2018) Opioid analgesics in the pharmacotherapy of pain, when in practice it is worth choosing tapentadol. BÓL 19:1, pages 51-53.
Crossref
Crossref
Jessie S Channell & Stephan Schug. (2018) Toxicity of tapentadol: a systematic review. Pain Management 8:5, pages 327-339.
Crossref
Crossref
Lynn Ang, Nathan Cowdin, Kara Mizokami-Stout & Rodica Pop-Busui. (2018) Update on the Management of Diabetic Neuropathy. Diabetes Spectrum 31:3, pages 224-233.
Crossref
Crossref
Renata Zajączkowska, Barbara Przewłocka, Magdalena Kocot-Kępska, Joanna Mika, Wojciech Leppert & Jerzy Wordliczek. (2018) Tapentadol – A representative of a new class of MOR-NRI analgesics. Pharmacological Reports 70:4, pages 812-820.
Crossref
Crossref
Sonia Torres-Sanchez, Gisela Da Silva Borges, Juan A. Mico & Esther Berrocoso. (2018) Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain. Neuropharmacology 135, pages 202-210.
Crossref
Crossref
Zohaib Iqbal, Shazli Azmi, Rahul Yadav, Maryam Ferdousi, Mohit Kumar, Daniel J. Cuthbertson, Jonathan Lim, Rayaz A. Malik & Uazman Alam. (2018) Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clinical Therapeutics 40:6, pages 828-849.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert TaylorJrJr, Jo Ann LeQuang, Robert B. Raffa & John Bisney. (2018) Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain. Pain and Therapy 7:1, pages 37-57.
Crossref
Crossref
Vera Bril, Ari Breiner, Bruce A. Perkins & Douglas Zochodne. (2018) Neuropathy. Canadian Journal of Diabetes 42, pages S217-S221.
Crossref
Crossref
. (2018)
10. Microvascular Complications and Foot Care:
Standards of Medical Care in Diabetes—2018
. Diabetes Care 41:Supplement_1, pages S105-S118.
Crossref
Crossref
Anna Tedeschi, Alessandra De Bellis, Piergiorgio Francia, Arianna Bernini, Marco Perini, Elisabetta Salutini & Roberto Anichini. (2018) Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes. Journal of Diabetes Research 2018, pages 1-6.
Crossref
Crossref
Michael Saulino. 2018. Challenging Neuropathic Pain Syndromes. Challenging Neuropathic Pain Syndromes
167
175
.
Mark Holtsman & Charity Hale. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
385
388.e1
.
Ariane Stollenwerk, Melanie Sohns, Fabian Heisig, Christian Elling & Detlef von Zabern. (2017) Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic. Advances in Therapy 35:1, pages 12-30.
Crossref
Crossref
Aaron I. Vinik, Carolina Casellini & Serina Neumann. 2018. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
275
353
.
Aaron I. Vinik, Carolina Casellini & Serina Neumann. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
1
80
.
Aaron I. Vinik, Carolina Casellini & Serina Neuman. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
1
82
.
Andrea L. NicolRobert W. HurleyHonorio T. Benzon. (2017) Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials. Anesthesia & Analgesia 125:5, pages 1682-1703.
Crossref
Crossref
Lisa M. Wilson, Ritu Sharma, Sydney M. Dy, Julie M. Waldfogel & Karen A. Robinson. (2017) Searching ClinicalTrials.gov did not change the conclusions of a systematic review. Journal of Clinical Epidemiology 90, pages 127-135.
Crossref
Crossref
Gur Prasad Dureja, Paramanand N Jain, Muralidhar Joshi, Ashok Saxena, Gautam Das, Jaishid Ahdal & Prashant Narang. (2017) Addressing the barriers related with opioid therapy for management of chronic pain in India. Pain Management 7:4, pages 311-330.
Crossref
Crossref
Joseph V PergolizziJrJr, Frank Breve, Robert TaylorJrJr, Robert B Raffa, Stephani E Strasburger & Jo Ann LeQuang. (2017) Considering tapentadol as a first-line analgesic: 14 questions. Pain Management 7:4, pages 331-339.
Crossref
Crossref
Ralf Baron, Leopold Eberhart, Kai-Uwe Kern, Stefan Regner, Roman Rolke, Christian Simanski & Thomas Tölle. (2017) Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data. Pain Practice 17:5, pages 678-700.
Crossref
Crossref
Julie M. WaldfogelSuzanne Amato NesbitSydney M. DyRitu SharmaAllen ZhangLisa M. WilsonWendy L. BennettHsin-Chieh YehYohalakshmi ChelladuraiDorianne FeldmanKaren A. Robinson. (2017) Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life. Neurology 88:20, pages 1958-1967.
Crossref
Crossref
Silvia FranchiGiada AmodeoMarta GandollaGiorgia MoschettiAlberto Emilio PaneraiPaola Sacerdote. (2017) Effect of Tapentadol on Splenic Cytokine Production in Mice. Anesthesia & Analgesia 124:3, pages 986-995.
Crossref
Crossref
Liping Zhang, Xiaoyu Yan, Sayori Nobe, Peter Zannikos, Mila Etropolski & Partha Nandy. (2016) Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach. Clinical Drug Investigation 37:3, pages 273-283.
Crossref
Crossref
. (2017) 10. Microvascular Complications and Foot Care. Diabetes Care 40:Supplement_1, pages S88-S98.
Crossref
Crossref
Rodica Pop-Busui, Andrew J.M. BoultonEva L. Feldman, Vera Bril, Roy Freeman, Rayaz A. Malik, Jay M. Sosenko & Dan Ziegler. (2017) Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 40:1, pages 136-154.
Crossref
Crossref
Ryan Murphy & Jonas Sokolof. 2017. Comprehensive Pain Management in the Rehabilitation Patient. Comprehensive Pain Management in the Rehabilitation Patient
107
118
.
Peter Keogh & Vivek Mehta. (2016) Recent Advances in the Pharmacological Management of Neuropathic Pain. Current Anesthesiology Reports 6:4, pages 327-333.
Crossref
Crossref
Richard M Langford, Roger Knaggs, Paul Farquhar-Smith & Anthony H Dickenson. (2016) Is tapentadol different from classical opioids? A review of the evidence. British Journal of Pain 10:4, pages 217-221.
Crossref
Crossref
Richard W. Simpson & John H. Wlodarczyk. (2016) Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain. Diabetes Care 39:9, pages 1493-1500.
Crossref
Crossref
Michael Saulino & Justin F. Averna. (2016) Evaluation and Management of SCI-Associated Pain. Current Pain and Headache Reports 20:9.
Crossref
Crossref
Ioannis N. Petropoulos, Saad Javed, Shazli Azmi, Adnan Khan, Georgios Ponirakis & Rayaz A. Malik. (2016) Diabetic neuropathy and painful diabetic neuropathy in the Middle East and North Africa (MENA) region: Much work needs to be done. Journal of Taibah University Medical Sciences 11:4, pages 284-294.
Crossref
Crossref
Ralf Baron, Jan‐Peter Jansen, Andreas Binder, Manuel Pombo‐Suarez, Lieven Kennes, Matthias Müller, Dietmar Falke & Ilona Steigerwald. (2015)
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial
. Pain Practice 16:5, pages 600-619.
Crossref
Crossref
Ralf Baron, Rudolf Likar, Emilio Martin‐Mola, Francisco J. Blanco, Lieven Kennes, Matthias Müller, Dietmar Falke & Ilona Steigerwald. (2015)
Effectiveness of Tapentadol Prolonged Release (
PR
) Compared with Oxycodone/Naloxone
PR
for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study
. Pain Practice 16:5, pages 580-599.
Crossref
Crossref
Aaron I. Vinik. (2016) Diabetic Sensory and Motor Neuropathy. New England Journal of Medicine 374:15, pages 1455-1464.
Crossref
Crossref
Ryan B. Griggs, Renee R. Donahue, Braxton G. Adkins, Katie L. Anderson, Olivier Thibault & Bradley K. Taylor. (2016) Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes. The Journal of Pain 17:3, pages 359-373.
Crossref
Crossref
Escarlata López Ramírez, D. M. Muñoz Carmona, J. Contreras Martínez & A. de la Torre Luque. (2016) Tapentadol in the management of opioid-naïve patients with cancer pain. Revista de la Sociedad Española del Dolor 23.
Crossref
Crossref
Michael Brownlee, Lloyd P. Aiello, Mark E. Cooper, Aaron I. Vinik, Jorge Plutzky & Andrew J.M. Boulton. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1484
1581
.
Andrew J.M. Boulton & Rayaz A. Malik. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
920
933.e5
.
Tiffany Zhang. 2016. Peripheral Nerve Entrapments. Peripheral Nerve Entrapments
19
25
.
Jeffrey J Ellis, Alesia B Sadosky, Laura L Ten Eyck, Pallavi Mudumby, Joseph C Cappelleri, Lilian Ndehi, Brandon T Suehs & Bruce Parsons. (2015) A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine. BMC Health Services Research 15:1.
Crossref
Crossref
S. Javed, U. Alam & R. A. Malik. (2015) Burning through the pain: treatments for diabetic neuropathy. Diabetes, Obesity and Metabolism 17:12, pages 1115-1125.
Crossref
Crossref
Qingqin S. Li, Peter Cheng, Reyna Favis, Alan Wickenden, Gary Romano & Hao Wang. (2015) SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity. The Clinical Journal of Pain 31:11, pages 976-982.
Crossref
Crossref
Robert Buynak, Stephen A. Rappaport, Kevin Rod, Pierre Arsenault, Fabian Heisig, Christine Rauschkolb & Mila Etropolski. (2015) Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial. Clinical Therapeutics 37:11, pages 2420-2438.
Crossref
Crossref
Hongki Lee, Virginia De Vito, Mario Giorgi & Hyoin Yun. (2015) Synergistic interaction between tapentadol and flupirtine in the rat orafacial formalin test. European Journal of Pharmacology 762, pages 350-356.
Crossref
Crossref
R. Andrew Moore, Philip J. Wiffen, Christopher Eccleston, Sheena Derry, Ralf Baron, Rae F. Bell, Andrea D. Furlan, Ian Gilron, Simon Haroutounian, Nathaniel P. Katz, Arthur G. Lipman, Stephen Morley, Paul M. Peloso, Steve N. Quessy, Kate Seers, Scott A. Strassels & Sebastian Straube. (2015) Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain. Pain 156:8, pages 1382-1395.
Crossref
Crossref
Nanna B Finnerup & Nadine Attal. (2015) Tapentadol prolonged release in the treatment of neuropathic pain related to diabetic polyneuropathy—Authors' reply. The Lancet Neurology 14:7, pages 685-686.
Crossref
Crossref
Christian Elling, Maja Galic & Ilona Steigerwald. (2015) Tapentadol prolonged release in the treatment of neuropathic pain related to diabetic polyneuropathy. The Lancet Neurology 14:7, pages 684-685.
Crossref
Crossref
Ralf Baron, Emilio Martin‐Mola, Matthias Müller, Cecile Dubois, Dietmar Falke & Ilona Steigerwald. (2014)
Effectiveness and Safety of Tapentadol Prolonged Release (
PR
) Versus a Combination of Tapentadol
PR
and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study
. Pain Practice 15:5, pages 455-470.
Crossref
Crossref
Ralf Baron, Uwe Kern, Matthias Müller, Cecile Dubois, Dietmar Falke & Ilona Steigerwald. (2014) Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study. Pain Practice 15:5, pages 471-486.
Crossref
Crossref
Boaz G. Samolsky Dekel, Sivia Ghedini, Alberto Gori, Alessio Vasarri, GianFranco Di Nino & Rita M. Melotti. (2015) Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain. Pain and Therapy 4:1, pages 107-117.
Crossref
Crossref
Michelle Kaku, Aaron Vinik & David M. Simpson. (2015) Pathways in the Diagnosis and Management of Diabetic Polyneuropathy. Current Diabetes Reports 15:6.
Crossref
Crossref
Uwe Richter, Susanne Waldmann-Rex & Ute Lehmann. (2014) Konsekutive Umstellung auf Tapentadol PR verbessert Analgesie und Lebensqualität bei Patienten mit starken und chronischen Schmerzen unter Tramadol > 300 mg/dConversion to tapentadol PR improves analgesia and quality of life in patients with severe and chronic pain despite using tramadol > 300 mg/d. Wiener klinische Wochenschrift 127:11-12, pages 477-487.
Crossref
Crossref
S. Ramaswamy, S. Chang & V. Mehta. (2015) Tapentadol - the evidence so far. Anaesthesia 70:5, pages 518-522.
Crossref
Crossref
Nadine Attal & Didier Bouhassira. (2015) Pharmacotherapy of neuropathic pain. Pain 156:Supplement 1, pages S104-S114.
Crossref
Crossref
Casandra J Rosenberg & James C Watson. (2015) Treatment of painful diabetic peripheral neuropathy. Prosthetics & Orthotics International 39:1, pages 17-28.
Crossref
Crossref
Richard L. Rauck. (2015) Response to Letter by Dr. Engel. Pain Medicine 16:2, pages 404.2-406.
Crossref
Crossref
Sherwyn Schwartz, Mila S. Etropolski, Douglas Y. Shapiro, Christine Rauschkolb, Aaron I. Vinik, Bernd Lange, Kimberly Cooper, Ilse Van Hove & Juergen Haeussler. (2014) A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy. Clinical Drug Investigation 35:2, pages 95-108.
Crossref
Crossref
C. Sommer, P. Welsch, P. Klose, R. Schaefert, F. Petzke & W. Häuser. (2014) Opioide bei chronischem neuropathischem SchmerzOpioids in chronic neuropathic pain. Der Schmerz 29:1, pages 35-46.
Crossref
Crossref
Saad Javed, Ioannis N. Petropoulos, Uazman Alam & Rayaz A. Malik. (2014) Treatment of painful diabetic neuropathy. Therapeutic Advances in Chronic Disease 6:1, pages 15-28.
Crossref
Crossref
Deepika Thakur, Sara Dickerson, Mohit Kumar Bhutani & Rod Junor. (2015) Impact of Prolonged-release Oxycodone/Naloxone on Outcomes Affecting Patients' Daily Functioning in Comparison With Extended-release Tapentadol: A Systematic Review. Clinical Therapeutics 37:1, pages 212-224.
Crossref
Crossref
Manuel J. Sánchez del Águila, Michael Schenk, Kai-Uwe Kern, Tanja Drost & Ilona Steigerwald. (2015) Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain. Clinical Therapeutics 37:1, pages 94-113.
Crossref
Crossref
A. Cowan, R.B. Raffa, C.S. Tallarida, R.J. Tallarida, T. Christoph, W. Schröder & T.M. Tzschentke. (2014) Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit. European Journal of Pain 18:8, pages 1148-1156.
Crossref
Crossref
Aaron I. Vinik, Douglas Y. Shapiro, Christine Rauschkolb, Bernd Lange, Keith Karcher, Deborah Pennett & Mila S. Etropolski. (2014) A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy. Diabetes Care 37:8, pages 2302-2309.
Crossref
Crossref
David M. Biondi, Jim Xiang, Mila Etropolski & Bruce Moskovitz. (2014) Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis. Clinical Drug Investigation 34:8, pages 565-576.
Crossref
Crossref
M. Niesters, P.L. Proto, L. Aarts, E.Y. Sarton, A.M. Drewes & A. Dahan. (2014) Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. British Journal of Anaesthesia 113:1, pages 148-156.
Crossref
Crossref
Susanne Waldmann-Rex, Kai-Uwe Kern & Doris Krings. (2014) Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retardTapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone. MMW - Fortschritte der Medizin 156:S13, pages 54-63.
Crossref
Crossref
Richard L. Rauck, Srinivas Nalamachu, James E. Wild, George S. Walker, Cynthia Y. Robinson, Charles S. Davis & Stephen J. Farr. (2014) Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study. Pain Medicine 15:6, pages 975-985.
Crossref
Crossref
Rainer Sabatowski, Rüdiger Scharnagel, Anne Gyllensvärd & Ilona Steigerwald. (2014) Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial. Pain and Therapy 3:1, pages 17-29.
Crossref
Crossref
Michael Saulino. (2014) Spinal Cord Injury Pain. Physical Medicine and Rehabilitation Clinics of North America 25:2, pages 397-410.
Crossref
Crossref
Sonya J. Snedecor, Lavanya Sudharshan, Joseph C. Cappelleri, Alesia Sadosky, Sonam Mehta & Marc Botteman. (2014) Systematic Review and Meta-Analysis of Pharmacological Therapies for Painful Diabetic Peripheral Neuropathy. Pain Practice 14:2, pages 167-184.
Crossref
Crossref
Marni Greig, Solomon Tesfaye, Dinesh Selvarajah & Iain D. Wilkinson. 2014. Diabetes and the Nervous System. Diabetes and the Nervous System
559
578
.
Steven N. Sykes & Said R. Beydoun. 2014. Neuromuscular Disorders in Clinical Practice. Neuromuscular Disorders in Clinical Practice
1575
1592
.
. (2013) Neuropathie. Canadian Journal of Diabetes 37, pages S645-S646.
Crossref
Crossref
R. Viganò, A. Fanelli, D. Ghisi, G. Danelli & S. E. De Martinis. (2013) Il controllo del dolore nelle protesi totali di ginocchioManagement of pain after total knee replacement. LO SCALPELLO-OTODI Educational 27:3, pages 147-152.
Crossref
Crossref
Andrea D. Furlan & Angela Mailis-Gagnon. 2013. Neuropathic Pain. Neuropathic Pain
240
248
.
. 2013. Neuropathic Pain. Neuropathic Pain
217
314
.
. 2013. Neuropathic Pain. Neuropathic Pain
101
144
.
Timothy J. Atkinson, Jeffrey Fudin, Abhinetri Pandula & Maira Mirza. (2013) Medication Pain Management in the Elderly: Unique and Underutilized Analgesic Treatment Options. Clinical Therapeutics 35:11, pages 1669-1689.
Crossref
Crossref
Magdalena Zychowska, Ewelina Rojewska, Barbara Przewlocka & Joanna Mika. (2013) Mechanisms and pharmacology of diabetic neuropathy – experimental and clinical studies. Pharmacological Reports 65:6, pages 1601-1610.
Crossref
Crossref
Gina Games & Amber Hutchison. (2013) Tapentadol-ER for the Treatment of Diabetic Peripheral Neuropathy. The Consultant Pharmacist 28:10, pages 672-675.
Crossref
Crossref
Vera Bril, Bruce Perkins & Cory Toth. (2013) Neuropathie. Canadian Journal of Diabetes 37, pages S518-S521.
Crossref
Crossref
Ilona Steigerwald, Michael Schenk, Uwe Lahne, Peter Gebuhr, Dietmar Falke & Barbara Hoggart. (2013) Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain. Clinical Drug Investigation 33:9, pages 607-619.
Crossref
Crossref
Roy Freeman. (2013) New and Developing Drugs for the Treatment of Neuropathic Pain in Diabetes. Current Diabetes Reports 13:4, pages 500-508.
Crossref
Crossref
Martin Strohmeier, Susanne Waldmann-Rex & Karla Schwenke. (2013) Einfluss von Tapentadol retard auf die Funktionalität bei starken chronischen SchmerzenInfluence of tapentadol retard on functional parameters in patients with severe chronic pain — Is there a benefit in daily life?. MMW - Fortschritte der Medizin 155:S4, pages 63-71.
Crossref
Crossref
Vera Bril, Bruce Perkins & Cory Toth. (2013) Neuropathy. Canadian Journal of Diabetes 37, pages S142-S144.
Crossref
Crossref
Daniel Ostertag & Matthias Strittmatter. (2013) Was hilft beim brennenden Schmerz?. DNP - Der Neurologe und Psychiater 14:4, pages 40-48.
Crossref
Crossref
Jan Gaertner & Christine Schiessl. (2013) Cancer Pain Management: What’s New?. Current Pain and Headache Reports 17:4.
Crossref
Crossref
Rafael Gálvez, Michael Schäfer, Guy Hans, Dietmar Falke & Ilona Steigerwald. (2013) Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study. Advances in Therapy 30:3, pages 229-259.
Crossref
Crossref
Robert Taylor, Joseph V. Pergolizzi & Robert B. Raffa. (2013) Tapentadol Extended Release for Chronic Pain Patients. Advances in Therapy 30:1, pages 14-27.
Crossref
Crossref
Kevin L. Farmer, Chengyuan Li & Rick T. Dobrowsky. (2012) Diabetic Peripheral Neuropathy: Should a Chaperone Accompany Our Therapeutic Approach?. Pharmacological Reviews 64:4, pages 880-900.
Crossref
Crossref
Richard B Silverman, Keith A CandiottiMelvin C Gitlin. (2012) Tapentadol extended-release: a recent addition to our analgesic armamentarium. Pain Management 2:5, pages 451-456.
Crossref
Crossref
D. Ziegler. (2012) NeuropathieNeuropathy. Der Diabetologe 8:5, pages 397-406.
Crossref
Crossref
Paul R. Nandi. (2012) Pain in neurological conditions. Current Opinion in Supportive & Palliative Care 6:2, pages 194-200.
Crossref
Crossref
I. D. Jeong, M. Camilleri, A. Shin, J. Iturrino, A. Boldingh, I. Busciglio, D. Burton, M. Ryks, D. Rhoten & A. R. Zinsmeister. (2012) A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Alimentary Pharmacology & Therapeutics 35:9, pages 1088-1096.
Crossref
Crossref
Joseph Pergolizzi, Cayetano Alegre, David Blake, Jaime Calvo Alén, Roberto Caporali, Hans‐Raimund Casser, Gerardo Correa‐Illanes, Pedro Fernandes, Eugenio Galilea, Richard Jany, Anthony Jones, Othmane Mejjad, Jadranka Morovic‐Vergles, Ángel Oteo Álvaro, Francisco J. Radrigán Araya, Maria Eugénia C. Simões & Generoso Uomo. (2011) Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol. Pain Practice 12:4, pages 290-306.
Crossref
Crossref
Marko Obradovic, Robert Ikenberg, Nadine Hertel, Fernando Antoñanzas, Rafael Gálvez & Hiltrud Liedgens. (2012) Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs. Clinical Therapeutics 34:4, pages 926-943.
Crossref
Crossref
Victor Mendis. (2012) Role of tapentadol in pain management. British Journal of Hospital Medicine 73:3, pages 143-147.
Crossref
Crossref
Athina Vadalouca, Efklidis Raptis, Eleni Moka, Panagiotis Zis, Panagiota Sykioti & Ioanna Siafaka. (2011) Pharmacological Treatment of Neuropathic Cancer Pain: A Comprehensive Review of the Current Literature. Pain Practice 12:3, pages 219-251.
Crossref
Crossref
Sheridan M. Hoy. (2012) Tapentadol Extended Release. Drugs 72:3, pages 375-393.
Crossref
Crossref
Tammy J. LindsayKirsten VitrikasMichael TemporalChristopher M. Herndon. (2012) Diabetic Neuropathic Pain: Real World Treatment Options. Clinical Medicine Insights: Therapeutics 4, pages CMT.S7266.
Crossref
Crossref
&NA;. (2011) Tapentadol immediate- and extended-release: a guide to its use in acute and chronic pain. Drugs & Therapy Perspectives 27:12, pages 1-6.
Crossref
Crossref
N. Attal. (2011) Avancées dans le traitement pharmacologique des douleurs neuropathiques. Revue Neurologique 167:12, pages 930-937.
Crossref
Crossref
Andrea M. Vincent, Brian C. Callaghan, Andrea L. Smith & Eva L. Feldman. (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nature Reviews Neurology 7:10, pages 573-583.
Crossref
Crossref
Chris Pasero. (2011) Tapentadol for Multimodal Pain Management. Journal of PeriAnesthesia Nursing 26:5, pages 343-346.
Crossref
Crossref
Mario Andrés Leotau Rodríguez. (2011) Tapentadol, una nueva opción terapéutica. Revista Colombiana de Anestesiología 39:3, pages 375-385.
Crossref
Crossref
Craig T. Hartrick & Richard J. Rozek. (2011) Tapentadol in Pain Management. CNS Drugs 25:5, pages 359-370.
Crossref
Crossref